Martin Wilson insider trades: Rocket Pharmaceuticals (RCKT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Martin reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | RCKT | ↓ Sell | 75,364 | $3.40 | $256K | Direct | Sep 15, 2026 (4d) |
| Aug 18, 2026 | RCKT | ↓ Sell | 631 | $3.38 | $2K | Direct | Aug 20, 2026 (2d) |
| Aug 13, 2026 | RCKT | ↓ Sell | 3,493 | $3.38 | $12K | Direct | Aug 17, 2026 (4d) |
| May 19, 2026 | RCKT | ↓ Sell | 662 | $3.01 | $2K | Direct | May 21, 2026 (2d) |
| May 13, 2026 | RCKT | ↓ Sell | 3,361 | $3.61 | $12K | Direct | May 14, 2026 (1d) |
| Feb 18, 2026 | RCKT | ↓ Sell | 1,376 | $3.34 | $5K | Direct | Feb 20, 2026 (2d) |
| Feb 13, 2026 | RCKT | ↓ Sell | 12,253 | $3.31 | $41K | Direct | Feb 18, 2026 (5d) |
| Nov 18, 2025 | RCKT | ↓ Sell | 1,646 | $2.98 | $5K | Direct | Nov 20, 2025 (2d) |
| Aug 19, 2025 | RCKT | ↓ Sell | 1,592 | $3.04 | $5K | Direct | Aug 20, 2025 (1d) |
| Aug 14, 2025 | RCKT | ↓ Sell | 12,109 | $3.02 | $37K | Direct | Aug 18, 2025 (4d) |
| May 20, 2025 | RCKT | ↓ Sell | 587 | $6.45 | $4K | Direct | May 22, 2025 (2d) |
| May 16, 2025 | RCKT | ↓ Sell | 946 | $6.53 | $6K | Direct | May 20, 2025 (4d) |
| Feb 21, 2025 | RCKT | ↓ Sell | 3,222 | $10.58 | $34K | Direct | Feb 25, 2025 (4d) |
| Nov 21, 2024 | RCKT | ↓ Sell | 1,175 | $13.05 | $15K | Direct | Nov 25, 2024 (4d) |
| Aug 16, 2024 | RCKT | ↓ Sell | 1,027 | $18.50 | $19K | Direct | Aug 20, 2024 (4d) |
| May 16, 2024 | RCKT | ↓ Sell | 1,048 | $23.35 | $24K | Direct | May 20, 2024 (4d) |
| Feb 29, 2024 | RCKT | ↓ Sell | 4,100 | $29.33 | $120K | Direct | Mar 4, 2024 (4d) |
| Feb 16, 2024 | RCKT | ↓ Sell | 3,576 | $29.84 | $107K | Direct | Feb 21, 2024 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RCKT insiders
Open-market trades in the last 12 months
About Martin Wilson's insider trades
Martin Wilson is General Counsel at Rocket Pharmaceuticals (RCKT). Since Feb 16, 2024, Martin has reported no open-market purchases and 18 sales worth $706K on SEC Form 4. In the last 12 months: 8 sales ($335K).
Their filings also include grants and awards (10 filings), option exercises (3 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RCKT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.